In search of a new pharmacological treatment for drug and alcohol addiction: N-methyl-D-aspartate (NMDA) antagonists. (Q33856557)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10706971%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

review article

1 reference

title

In search of a new pharmacological treatment for drug and alcohol addiction: N-methyl-D-aspartate (NMDA) antagonists (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10706971%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10706971%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Piotr Popik

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10706971%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1

Bisaga A

1 reference

29 July 2017

1 April 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10706971%20AND%20SRC:MED&resulttype=core&format=json

Drug and Alcohol Dependence

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10706971%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10706971%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10706971%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

1-15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10706971%20AND%20SRC:MED&resulttype=core&format=json

Amantadine may facilitate detoxification of cocaine addicts

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Dextromethorphan. An overview of safety issues

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Acamprosate enhances N-methyl-D-apartate receptor-mediated neurotransmission but inhibits presynaptic GABA(B) receptors in nucleus accumbens neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

The expression of both amphetamine-conditioned place preference and pentylenetetrazol-conditioned place aversion is attenuated by the NMDA receptor antagonist (+/-)-CPP.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Intraaccumbens administration of NMDA receptor antagonist (+/-)-CPP prevents locomotor activation conditioned by morphine and amphetamine in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

NMDA receptor antagonists prevent conditioned activation of intracranial self-stimulation in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Excitatory amino acid receptor antagonist kynurenic acid attenuates rewarding potential of morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Opiate withdrawal with dextromethorphan

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Nitric oxide synthesis inhibition does not affect brain stimulation reward.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Efficacy of disulfiram: a reply to Hughes and Cook

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Competitive and glycine/NMDA receptor antagonists attenuate withdrawal-induced behaviours and increased hippocampal acetylcholine efflux in morphine-dependent rats

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Inhibitory effects of ibogaine on cocaine self-administration in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

The NMDA receptor and cocaine: evidence that MK-801 can induce behavioral sensitization effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Morphine-induced potentiation of brain stimulation reward is enhanced by MK-801.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Differential symptom reduction in depressed cocaine abusers treated with psychotherapy and pharmacotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

d-Cycloserine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label study

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Effects of dopaminergic and glutamatergic receptor antagonists on the establishment and expression of conditioned locomotion to cocaine in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

The effects of memantine on the subjective, reinforcing and cardiovascular effects of cocaine in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Possible abuse potential of the NMDA antagonist MK-801.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Evidence for N-methyl-D-aspartate receptor mediation of cocaine induced corticosterone release and cocaine conditioned stimulant effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

The involvement of NMDA receptors in acute and chronic effects of ethanol

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents--preclinical studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Homologies and differences in the action of drugs of abuse and a conventional reinforcer (food) on dopamine transmission: an interpretative framework of the mechanism of drug dependence.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

The NMDA receptor antagonist dizocilpine (MK-801) stereoselectively inhibits morphine-induced place preference conditioning in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

A MEDICAL TREATMENT FOR DIACETYLMORPHINE (HEROIN) ADDICTION. A CLINICAL TRIAL WITH METHADONE HYDROCHLORIDE.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

N-methyl-D-aspartate (NMDA) receptors, mu and kappa opioid tolerance, and perspectives on new analgesic drug development

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Pharmacological treatment of alcohol dependence: a review of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Clonidine blocks acute opiate-withdrawal symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

The dysphoria of heroin addiction.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Amantadine does not reduce cocaine use or craving in cocaine-dependent methadone maintenance patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Effects of nitric oxide synthase inhibitors on cocaine sensitization.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

The effect of MK-801 and other antagonists of NMDA-type glutamate receptors on brain-stimulation reward

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal. Medication development issues for opiate addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Modifications of the behavioral profile of non-competitive NMDA receptor antagonists, memantine, amantadine and (+)MK-801 after chronic administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

The NMDA antagonist dizocilpine (MK801) attenuates motivational as well as somatic aspects of naloxone precipitated opioid withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

The noncompetitive NMDA antagonist MK-801 fails to block amphetamine-induced place conditioning in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Evidence for alcohol anti-craving properties of memantine

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Clonidine in morphine withdrawal. Differential effects on signs and symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

MK-801 prevents the development of behavioral sensitization during repeated morphine administration

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Cellular mechanisms of behavioral sensitization to drugs of abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Amantadine in the early treatment of cocaine dependence: a double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Effects of post-ethanol administration of NMDA and non-NMDA receptor antagonists on the development of ethanol tolerance in C57B1 mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

NMDA antagonist inhibits rapid tolerance to ethanol

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

D-cycloserine enhances rapid tolerance to ethanol motor incoordination.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Treatment of Cocaine Dependence in Methadone Maintenance Clients: A Pilot Study Comparing the Efficacy of Desipramine and Amantadine

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Psychotogenicity and N-methyl-D-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

The anti-craving drug acamprosate inhibits the conditioned place aversion induced by naloxone-precipitated morphine withdrawal in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

The competitive NMDA receptor antagonist, CGP 39551, inhibits ethanol withdrawal seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

An NMDA receptor antagonist reduces ethanol preference in untrained but not trained rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Excitatory amino acids as a final common pathway for neurologic disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

The effect of MK-801 and SCH23390 on the expression and sensitization of morphine-induced oral stereotypy

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Acamprosate (calcium acetylhomotaurinate) enhances the N-methyl-D-aspartate component of excitatory neurotransmission in rat hippocampal CA1 neurons in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Neurobiological similarities in depression and drug dependence: a self-medication hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Medication development of ibogaine as a pharmacotherapy for drug dependence.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Are detoxification programmes effective?

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

2-Amino-7-phosphonoheptanoic acid, a selective antagonist of N-methyl-D-aspartate, prevents barbital withdrawal-induced convulsions and the elevation of cerebellar cyclic GMP in dependent rats

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Lesions of the basolateral amygdala abolish the ability of drug associated cues to reinstate responding during withdrawal from self-administered cocaine

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Safety review of adult clinical trial experience with lamotrigine

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

MK-801 potently inhibits alcohol withdrawal seizures in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Reinforcing properties of morphine and naloxone revealed by conditioned place preferences: a procedural examination.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Mechanism of action of acamprosate. Part I. Characterization of spermidine-sensitive acamprosate binding site in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Molecular and cellular basis of addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Dextromethorphan blocks N-methyl-D-aspartate-induced currents and voltage-operated inward currents in cultured cortical neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Conditioned narcotic withdrawal in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Conditioning factors in drug abuse: can they explain compulsion?

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Biochemical actions of chronic ethanol exposure in the mesolimbic dopamine system

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Ethanol-reinforced behaviour in the rat: effects of uncompetitive NMDA receptor antagonist, memantine

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Factors that predict individual vulnerability to amphetamine self-administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

The NMDA antagonist, dizocilpine, enhances cocaine reinforcement without influencing mesoaccumbens dopamine transmission.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Mesolimbic NMDA receptors are implicated in the expression of conditioned morphine reward.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Inhibition of reinforcing effects of morphine and naloxone-precipitated opioid withdrawal by novel glycine site and uncompetitive NMDA receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

L-NAME and MK-801 attenuate sensitization to the locomotor-stimulating effect of cocaine.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Inhibition of nitric oxide synthesis reduces intravenous cocaine self-administration in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Dextromethorphan reduces intravenous cocaine self-administration in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

NMDA receptors in the nucleus accumbens modulate intravenous cocaine but not heroin self-administration in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Mechanism of action of acamprosate. Part II. Ethanol dependence modifies effects of acamprosate on NMDA receptor binding in membranes from rat cerebral cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Possible involvement of NMDA receptor-mediated transmission in barbiturate physical dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Dizocilpine prevents the development of tolerance to ethanol-induced error on a circular maze test.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Systemic pretreatment with MK-801 (dizocilpine) increases breaking points for self-administration of cocaine on a progressive-ratio schedule in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Synergistic effects of cocaine and dizocilpine (MK-801) on brain stimulation reward.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

GABA and nucleus accumbens glutamate neurotransmission modulate ethanol self-administration in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

The neural basis of drug craving: an incentive-sensitization theory of addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

A pilot study of dextromethorphan in naloxone-precipitated opiate withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

The effect of lamotrigine on naloxone-precipitated opiate withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Development and expression of sensitization to cocaine's reinforcing properties: role of NMDA receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Nicotine vs. placebo gum in the alleviation of withdrawal during smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Low-affinity NMDA receptor channel blockers inhibit acquisition of intravenous morphine self-administration in naive mice

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Ibogaine and cocaine abuse: pharmacological interactions at dopamine and serotonin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

A preliminary investigation of ibogaine: case reports and recommendations for further study

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

The NMDA antagonist dizocilpine (M K801) attenuates tolerance to nicotine in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Behavioural and neurochemical adaptations to nicotine in rats: influence of NMDA antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Behavioural and biochemical adaptations to nicotine in rats: influence of MK801, an NMDA receptor antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Acamprosate and alcohol: II. Effects on alcohol withdrawal in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Acamprosate suppresses the expression of morphine-induced sensitization in rats but does not affect heroin self-administration or relapse induced by heroin or stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Diazepam dependence prevented by glutamate antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist, MK-801.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

The NMDA receptor antagonist dizocilpine differentially affects environment-dependent and environment-independent ethanol tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Double-blind comparison of amantadine and bromocriptine for ambulatory withdrawal from cocaine dependence.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

N-methyl-D-aspartic acid-receptor antagonists block morphine-induced conditioned place preference in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Interactions of MK-801 and GYKI 52466 with morphine and amphetamine in place preference conditioning and behavioural sensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Further in vivo studies on attenuating morphine withdrawal: isoform-selective nitric oxide synthase inhibitors differ in efficacy.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

D-cycloserine acts as a partial agonist at the glycine modulatory site of the NMDA receptor expressed in Xenopus oocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Comparison of Amantadine and Desipramine Combined with Psychotherapy for Treatment of Cocaine Dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Blockade of chronic tolerance to ethanol by the NMDA antagonist, (+)-MK-801.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Acamprosate (calciumacetylhomotaurinate) decreases postsynaptic potentials in the rat neocortex: possible involvement of excitatory amino acid receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Pharmacotherapy improves treatment outcome in depressed cocaine addicts.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021

Does dizocilpine (MK-801) selectively block the enhanced responsiveness to repeated amphetamine administration?

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900107-6

7 January 2021